Key facts
- This page summarizes Keith Murphy's Form 4 filing for ORGANOVO HOLDINGS, INC. (VIVS).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 12 Oct 2021, 18:00.
Keith Murphy - 07 Oct 2021 Form 4 Insider Report for ORGANOVO HOLDINGS, INC. (VIVS)
- Reporting relationship
- Executive Chairman, Director
- Issuer ticker
- VIVS
- Reported as of
- 07 Oct 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Oct 2021, 18:00:47 UTC
- Prior SEC filing
- 22 Sep 2021
- Next SEC filing
- 20 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tom Jurgensen, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Keith Murphy filed Form 4 for ORGANOVO HOLDINGS, INC. (VIVS) on 12 Oct 2021.
Change
- Previous filing in this sequence was filed on 22 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ONVO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +60,000
- Change %
- Price
- $0.000000
- Shares after
- 60,000
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $6.70
- Footnotes
- F1
ONVO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +60,000
- Change %
- Price
- $0.000000
- Shares after
- 60,000
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $6.70
- Footnotes
- F2
ONVO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +17,500
- Change %
- Price
- $0.000000
- Shares after
- 17,500
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,500
- Exercise price
- $6.70
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The option becomes exercisable, if at all, if the 45-day moving average closing price of the Issuer's common stock on The Nasdaq Stock Market LLC exceeds $30.00 per share.
Footnote F2
The option becomes exercisable, if at all, if the 45-day moving average closing price of the Issuer's common stock on The Nasdaq Stock Market LLC exceeds $35.00 per share.
Footnote F3
The option shares shall vest and become exercisable on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders.